BioArctic AB (publ)
BRCTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $14,121 | $392,119 | $1,289,612 | $101,236 |
| % Growth | -96.4% | -69.6% | 1,173.9% | – |
| Cost of Goods Sold | $1,294 | $20,489 | $11,444 | $11,849 |
| Gross Profit | $12,827 | $371,630 | $1,278,168 | $89,387 |
| % Margin | 90.8% | 94.8% | 99.1% | 88.3% |
| R&D Expenses | $10,116 | $111,915 | $84,633 | $96,275 |
| G&A Expenses | $31,660 | $29,482 | $27,170 | $30,914 |
| SG&A Expenses | $5,330 | $49,052 | $46,001 | $46,486 |
| Sales & Mktg Exp. | $18,675 | $19,570 | $18,831 | $15,572 |
| Other Operating Expenses | $0 | $31,589 | $72,270 | $124 |
| Operating Expenses | $15,446 | $192,556 | $202,904 | $142,885 |
| Operating Income | -$2,619 | $179,074 | $1,075,264 | -$53,498 |
| % Margin | -18.5% | 45.7% | 83.4% | -52.8% |
| Other Income/Exp. Net | $401 | -$7,597 | -$9,288 | $9,592 |
| Pre-Tax Income | -$2,218 | $171,477 | $1,065,976 | -$43,906 |
| Tax Expense | $6,982 | $74,926 | $44,505 | -$12,444 |
| Net Income | -$86,872 | $96,552 | $1,021,472 | -$31,462 |
| % Margin | -615.2% | 24.6% | 79.2% | -31.1% |
| EPS | -0.1 | 1.09 | 11.55 | -0.36 |
| % Growth | -109.2% | -90.6% | 3,308.3% | – |
| EPS Diluted | -0.1 | 1.09 | 11.53 | -0.36 |
| Weighted Avg Shares Out | 88,584 | 88,530 | 88,459 | 88,329 |
| Weighted Avg Shares Out Dil | 88,584 | 88,530 | 88,593 | 88,329 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,111 | $8,475 | $4,946 | $10,250 |
| Interest Expense | $282 | $16,072 | $14,234 | $659 |
| Depreciation & Amortization | $357 | $0 | $0 | $0 |
| EBITDA | -$1,578 | $187,549 | $1,080,210 | -$43,247 |
| % Margin | -11.2% | 47.8% | 83.8% | -42.7% |